Cas:106946-74-1 N-Boc-L-isoleucinol manufacturer & supplier

We serve Chemical Name:N-Boc-L-isoleucinol CAS:106946-74-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

N-Boc-L-isoleucinol

Chemical Name:N-Boc-L-isoleucinol
CAS.NO:106946-74-1
Synonyms:2-Methyl-2-propanyl [(2S,3S)-1-hydroxy-3-methyl-2-pentanyl]carbamate;tert-Butyl [(2S,3S)-1-hydroxy-3-methylpentan-2-yl]carbamate;Carbamic acid, N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]-, 1,1-dimethylethyl ester;N-Boc-L-Isoleucinol;tert-butyl N-[(2S,3S)-1-hydroxy-3-methylpentan-2-yl]carbamate;MFCD00235929;Boc-Ile-ol
Molecular Formula:C11H23NO3
Molecular Weight:217.305
HS Code:2924199090

Physical and Chemical Properties:
Melting point:121-126ºC 0.6 mm Hg
Boiling point:319.3±25.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.454
PSA:58.56000
Exact Mass:217.167801
LogP:2.25

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 2810 6.1/PG 3
Packing Group:


Contact us for information like 2-Methyl-2-propanyl [(2S,3S)-1-hydroxy-3-methyl-2-pentanyl]carbamate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Boc-Ile-ol physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbamic acid, N-[(1S,2S)-1-(hydroxymethyl)-2-methylbutyl]-, 1,1-dimethylethyl ester Use and application,MFCD00235929 technical grade,usp/ep/jp grade.


Related News: While reactions requiring the use of metal catalysts may necessitate heating to temperatures of 160oC, and/or cooling to -60oC or lower, enzyme-catalyzed reactions instead run at temperatures in the region of ~10 – 40oC. 3-(4-methoxy-phenyl)-4-methyl-1-phenyl-4,5-dihydro-1H-pyrazole manufacturers He joins us at a pivotal time as our Jinkō® platform goes from strength to strength as we expand our portfolio of partnerships. Grégoire’s strategic and operational expertise will be a vital part of our future success in accelerating and de-risking clinical trials. 2-Cyclohexen-1-one,2-[4,4-dimethoxy-1-(phenylseleno)butyl]-5,5-dimethyl- suppliers In SLE, along with the pivotal TULIP phase III programme, anifrolumab continues to be evaluated in a long-term extension phase III trial.12 A phase II trial of anifrolumab in SLE using subcutaneous delivery has been completed. 3,3-dimethyl-1-nitroso-but-1-yne vendor & factory.